An 8-month-old female Great Pyrenees dog with chronic epistaxis and a history of gingival bleeding during shedding of deciduous teeth was evaluated for platelet function. Platelet morphology was normal at both the light and electron microscopic level. Platelet number and mean platelet volume were also normal. Platelet aggregation responses to adenosine diphosphate, collagen, platelet activating factor, and thrombin were markedly reduced, although shape change responses were normal. Clot retraction was markedly impaired. Monoclonal antibody (MoAb) Y2/51, a murine anti-human platelet β3 antibody that cross-reacts with canine platelet β3, and MoAb 5G11, a murine anti-dog platelet αIIbβ3 antibody, bound minimally to affected dog platelets, as demonstrated by flow cytometry. Binding of MoAb Y2/51 was not detectable by immunoblot. MoAb CAP1, a murine anti-dog fibrinogen receptor-induced binding site antibody, failed to bind to affected dog platelets, as demonstrated by flow cytometry. A reduction in glycoproteins αIIb and β3 was demonstrated by two-dimensional protein electrophoresis. This is the first reported case of type I Glanzmann's thrombasthenia in the dog that closely resembles the clinical syndrome and the platelet morphology described in type I Glanzmann's thrombasthenia of human beings.
BoudreauxMKCragerCDillonARStanzKToivio-KinnucanM:
Identification of an intrinsic platelet function defect in Spitz dogs.
J Vet Intern Med8:
93–98,
1994
2.
BoudreauxMKDillonARSpanoJS:
Enhanced platelet reactivity in heartworm-infected dogs.
Am J Vet Res50:
1544–1547,
1989
3.
BoudreauxMKDoddsWJSlausonDOCatalfamoJ:
Impaired cAMP metabolism associated with abnormal function of thrombopathic canine platelets.
Biochem Biophys Res Commun140:
595–601,
1986
4.
BoudreauxMKPanangalaVSBourneC:
A platelet activation-specific monoclonal antibody that recognizes a receptor-induced binding site on canine fibrinogen.
Vet Pathol33:
419–427,
1996
5.
BoudreauxMKWagner-MannCPurohitRHankesGSpanoJPabloLLeeSContiJ:
Platelet function testing in the pony.
Lab Anim Sci38:
448–451,
1988
6.
BrayPFShumanMA:
Identification of an abnormal gene for the GPIIIa subunit of the platelet fibrinogen receptor resulting in Glanzmann's thrombasthenia.
Blood75:
881–888,
1990
7.
BrinkhousKM:
Gene transfer in the hemophilias: retrospect and prospect.
Thromb Res67:
329–338,
1992
8.
BrinkhousKMSandbergHGarrisJBMattssonCPalmMGriggsTReadMS:
Purified human factor VIII pro-coagulant protein: comparative hemostasis response after infusions into hemophilic and von Willebrand disease dogs.
Proc Natl Acad Sci USA82:
8752–8756,
1985
9.
BurkCDNewmanPJLymanSGillJCollerBSPonczM:
A deletion in the gene for glycoprotein IIb associated with Glanzmann's thrombasthenia.
J Clin Invest87:
270–276,
1991
ChenYPDjaffarIPidardDSteinerBCieutatAMCaenJPRosaJP:
Ser-752 → Pro mutation in the cytoplasmic domain of integrin β3 subunit and defective activation of platelet integrin αIIbβ3 (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia.
Proc Natl Acad Sci USA89:
10169–10173,
1992
EisensmithRCFangBKayMALandenCNCrossREBellingerDAReadMSHuPCBrinkhousKMWooSLC:
Gene therapy for hemophilia B: cyclosporin treatment increases the persistence of adenovirus-mediated factor IX expression in hemophilia B dogs.
Blood84:
255a,
1994
[Abstract]
15.
GeorgeJNCaenJPNurdenAT:
Glanzmann's thrombasthenia: the spectrum of clinical disease.
Blood75:
1383–1395,
1990
16.
GilesARTinlinSGreenwoodR:
A canine model of hemophilic (factor VIII: C deficiency) bleeding.
Blood60:
727–730,
1982
17.
HagenINurdenABjerrumOJSolumNOCaenJ:
Immunochemical evidence for protein abnormalities in platelets from patients with Glanzmann's thrombasthenia and Bernard-Soulier syndrome.
J Clin Invest65:
722–731,
1980
18.
HarrisonPWilbournBDebiliNVainchenkerWBreton-GoriusJLawrieASMasseJMSavidgeGFCramerEM:
Uptake of plasma fibrinogen into the alpha granules of human megakaryocytes and platelets.
J Clin Invest84:
1320–1324,
1989
19.
JohnstoneIBLotzF:
An inherited platelet function defect in Basset hounds.
Can Vet J20:
211–215,
1979
20.
KatoAYamamotoKMiyazakiSJungSMMoroiMAokiN:
Molecular basis for Glanzmann's thrombasthenia (GT) in a compound heterozygote with glycoprotein IIb gene: a proposal for the classification of GT based on the biosynthetic pathway of glycoprotein IIb-IIIa complex.
Blood79:
3212–3218,
1992
21.
KunickiTJNurdenATPidardDRussellNRCaenJP:
Characterization of human platelet glycoprotein antigens giving rise to individual immunoprecipitates in crossed Immunoelectrophoresis.
Blood58:
1190–1197,
1981
22.
LaemmliUK:
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature227:
680–685,
1970
23.
LagesBWeissHJ:
Evidence for a role of glycoprotein IIb-IIIa, distinct from its ability to support aggregation, in platelet activation by ionophores in the presence of extracellular divalent cations.
Blood83:
2549–2559,
1994
24.
LaneJBrownMBernsteinIWilcoxPKSlichterSJNowinskiRC:
Serological and biochemical analysis of the PIA1 alloantigen of human platelets.
Br J Haematol50:
351–359,
1982
25.
LanzaFStierleAFournierDMoralesMAndreGNurdenATCazenaveJP:
A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg→214 Trp mutation.
J Clin Invest89:
1995–2004,
1992
26.
LittlewoodJDBarrowcliffeTW:
The development and characterization of antibodies to human factor VIII in haemophilic dogs.
Thromb Haemostasis57:
314–321,
1987
27.
McDonaldLE:
Reproductive patterns in dogs.
In:
Veterinary Endocrinology and Reproduction,
2nd ed.,
p. 410.
Lea & Febiger,
Philadelphia, PA,
1975
28.
NurdenATCaenJP:
An abnormal platelet glycoprotein pattern in three cases of Glanzmann's thrombasthenia.
Br J Haematol28:
253–259,
1974
29.
NurdenATRosaJPFournierDLegrandCDidryDParquetAPidardD:
A variant of Glanzmann's thrombasthenia with abnormal glycoprotein IIb-IIIa complexes in the platelet membrane.
J Clin Invest79:
962–969,
1987
RaymondSLDoddsWJ:
Platelet membrane glycoproteins in normal dogs and dogs with hemostatic defects.
J Lab Clin Med93:
607–613,
1979
32.
RyuTDavisJMSchwartzKA:
Dose-dependent platelet stimulation and inhibition induced by anti-PIA1 IgG.
J Lab Clin Med116:
91–99,
1990
33.
ScottMADavisJMSchwartzKA:
A new immunor-adiometric assay for canine platelet-associated immunoglobulin.
Blood84:
187a,
1994[Abstract]
34.
SharrowSO:
Overview of flow cytometry data.
In:
Current Protocols in Immunology,
ed. ColiganJEKruisbeekAMMarguliesDHShevachEMStroberW,
pp. 5.1.1–5.1.8.
John Wiley & Sons,
New York, NY,
1991
35.
SharrowSO:
Analysis of flow cytometry data.
In:
Current Protocols in Immunology,
ed. ColiganJEKruisbeekAMMarguliesDHShevachEMStroberW,
pp. 5.2.1–5.2.10.
John Wiley & Sons,
New York, NY,
1991
36.
ShulmanNRMarderVJHillerMCCollierEM:
Platelet and leukocyte isoantigens and their antibodies: serologic, physiologic and clinical studies.
Progr Hematol4:
222–304,
1964
37.
SimsekSHeyboerHde Bruijne-AdmiraalLGGoldschmedingRCuijpersHTMvon dem BorneAEGK:
Glanzmann's thrombasthenia caused by homozygosity for a splice defect that leads to deletion of the first coding exon of the glycoprotein IIIa mRNA.
Blood81:
2044–2049,
1993
38.
WeissHJKochwaS:
Studies of platelet function and proteins in 3 patients with Glanzmann's thrombasthenia.
J Lab Clin Med71:
153–165,
1968
39.
ZuckerMBPertJHHilgartnerMW:
Platelet function in a patient with thrombasthenia.
Blood28:
524–534,
1966
